FORTE Study Update - November 2023

November 14 2023

Thanks to your recruitment efforts, FORTE has hit the huge milestone of enrolling 1,000 participants to this important colorectal cancer prevention clinical trial! Keep up the good work!

How can you prepare to consent a patient at the FORTE baseline visit?

Tips & Tricks from accruing sites:

  • Make a sample form packet to review prior to the patient visit
  • Review the blood collection instructions
  • Prepare the stool kit - highlight the sections participants need to fill out independently for their attention
  • Review VisionTree instructions or prepare paper forms

Accrual Updates and Milestones (as of October 31, 2023)

Top accruing sites:

Kaiser Permanente – Vallejo – 583 accrued

UPMC-Presbyterian Hospital – 161 accrued

Park Nicollet Clinic - Saint Louis Park – 60 accrued

Most recent randomizations:

Kaiser Permanente-Vallejo – October 30, 2023

Regions Hospital – October 30, 2023

UCHealth University of Colorado Hospital – October 27, 2023

Centro Comprensivo de Cancer de UPR – October 27, 2023

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at: or 1(800) 477-7227.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.